|
|
.
See Category: Neoplasms
See Header: Malignant neoplasm of upper-inner quadrant of breast, female
ICD-10 (CM) Code and Descriptor
|
C50.212 |
Malignant neoplasm of upper-inner quadrant of left female breast
Diagnosis Valid for Female Patient Only
|
C50212 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 63.32%
|
23.82%
|
6.34%
|
2.57%
|
1.42%
|
0.84%
|
0.51%
|
0.39%
|
0.17%
|
0.19%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C50.212*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
20,839
|
20,967
|
|
80053
|
COMPREHEN METABOLIC PANEL |
13,693
|
13,693
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
13,674
|
13,677
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
11,555
|
11,586
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
11,241
|
11,252
|
|
77387
|
GUIDANCE FOR RADJ TX DLVR |
4,445
|
4,470
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
4,417
|
9,455
|
|
86300
|
IMMUNOASSAY TUMOR CA 15-3 |
4,305
|
4,577
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
3,617
|
3,617
|
|
J3010
|
FENTANYL CITRATE INJECTION |
3,434
|
6,105
|
|
J2405
|
ONDANSETRON HCL INJECTION |
3,416
|
18,710
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
3,320
|
5,470
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
3,179
|
4,701
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
3,091
|
25,670
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
2,947
|
95,361
|
|
77065
|
DX MAMMO INCL CAD UNI |
2,944
|
2,948
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
2,820
|
13,281
|
|
77066
|
DX MAMMO INCL CAD BI |
2,798
|
2,798
|
|
19301
|
PARTIAL MASTECTOMY |
2,412
|
2,412
|
|
77336
|
RADIATION PHYSICS CONSULT |
2,411
|
2,411
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C50.212 related to the following DRG Codes:
582-583
597-599
|
